JAMA publishes first phase 2b trial of MM120 (pharmaceutical LSD) for generalised anxiety disorder. Single treatment reduced symptoms for up to 12 weeks.
Major mental health advance.
#LSDResearch #AnxietyTreatment #Anxiety #GAD
JAMA publishes first phase 2b trial of MM120 (pharmaceutical LSD) for generalised anxiety disorder. Single treatment reduced symptoms for up to 12 weeks.
Major mental health advance.
#LSDResearch #AnxietyTreatment #Anxiety #GAD
A low (not micro) dose of LSD (26 µg) reduced EEG responses to neutral and happy faces, suggesting that low doses of LSD could alter emotional processing in the brain. #Neuroscience #LSDResearch #EEG
www.liebertpub.com/doi/abs/10.1...
www.liebertpub.com/doi/abs/10.1...
A low (not micro) dose of LSD (26 µg) reduced EEG responses to neutral and happy faces, suggesting that low doses of LSD could alter emotional processing in the brain. #Neuroscience #LSDResearch #EEG
www.liebertpub.com/doi/abs/10.1...
www.liebertpub.com/doi/abs/10.1...